Sartor, O., Scardino, P. T., McLeod, D. G., Schelhammer, P. F., D’Amico, A. V., & Halabi, S. (2007). 207: Management of Prostate-specific Antigen (PSA) Recurrence after Initial Definitive Local Therapy for Prostate Cancer: Updated Results from the Compare Registry. In Journal of Urology (Vol. 177, pp. 70–70). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1016/s0022-5347(18)30472-5

Sartor, Oliver, Peter T. Scardino, David G. McLeod, Paul F. Schelhammer, Anthony V. D’Amico, and Susan Halabi. “207: Management of Prostate-specific Antigen (PSA) Recurrence after Initial Definitive Local Therapy for Prostate Cancer: Updated Results from the Compare Registry.” In Journal of Urology, 177:70–70. Ovid Technologies (Wolters Kluwer Health), 2007. https://doi.org/10.1016/s0022-5347(18)30472-5.

Sartor O, Scardino PT, McLeod DG, Schelhammer PF, D’Amico AV, Halabi S. 207: Management of Prostate-specific Antigen (PSA) Recurrence after Initial Definitive Local Therapy for Prostate Cancer: Updated Results from the Compare Registry. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2007. p. 70–70.

Sartor, Oliver, et al. “207: Management of Prostate-specific Antigen (PSA) Recurrence after Initial Definitive Local Therapy for Prostate Cancer: Updated Results from the Compare Registry.” Journal of Urology, vol. 177, no. 4S, Ovid Technologies (Wolters Kluwer Health), 2007, pp. 70–70. Crossref, doi:10.1016/s0022-5347(18)30472-5.

Sartor O, Scardino PT, McLeod DG, Schelhammer PF, D’Amico AV, Halabi S. 207: Management of Prostate-specific Antigen (PSA) Recurrence after Initial Definitive Local Therapy for Prostate Cancer: Updated Results from the Compare Registry. Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2007. p. 70–70.